Literature DB >> 11145928

Estrogen and angiogenesis: A review.

D W Losordo1, J M Isner.   

Abstract

Multiple lines of evidence suggest that estrogen directly modulates angiogenesis via effects on endothelial cells. Under physiological conditions, angiogenesis is routinely observed in the uterus in association with fluctuations in the levels of circulating estradiol and other sex steroids. In pathological circumstances, such as breast cancer, a clear association between estrogen, estrogen receptor expression by endothelial cells, angiogenic activity, and/or tumor invasiveness has been made. Studies performed in our laboratory have revealed that estradiol accelerates functional endothelial recovery after arterial injury. Despite these consistent observations, the mechanisms by which estrogen regulates angiogenesis under physiological and pathological circumstances have not been defined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145928     DOI: 10.1161/01.atv.21.1.6

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  76 in total

1.  Hormone replacement therapy trials: an update.

Authors:  Claire S Duvernoy; Lori Mosca
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

2.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

3.  Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase.

Authors:  Isabella Baruscotti; Federica Barchiesi; Edwin K Jackson; Bruno Imthurn; Ruth Stiller; Jai-Hyun Kim; Sara Schaufelberger; Marinella Rosselli; Christopher C W Hughes; Raghvendra K Dubey
Journal:  Hypertension       Date:  2010-07-19       Impact factor: 10.190

4.  Estradiol-estrogen receptor: a key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells.

Authors:  Olga Ch Kousidou; Aikaterini Berdiaki; Dimitris Kletsas; Alexandros Zafiropoulos; Achilleas D Theocharis; George N Tzanakakis; Nikos K Karamanos
Journal:  Mol Oncol       Date:  2008-06-18       Impact factor: 6.603

5.  Loss of Estrogen-Related Receptor Alpha Facilitates Angiogenesis in Endothelial Cells.

Authors:  Neah Likhite; Vikas Yadav; Eric J Milliman; Danesh H Sopariwala; Sabina Lorca; Nithya P Narayana; Megha Sheth; Erin L Reineke; Vincent Giguère; Vihang Narkar
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

Review 6.  Heightened susceptibility: A review of how pregnancy and chemical exposures influence maternal health.

Authors:  Julia Varshavsky; Anna Smith; Aolin Wang; Elizabeth Hom; Monika Izano; Hongtai Huang; Amy Padula; Tracey J Woodruff
Journal:  Reprod Toxicol       Date:  2019-05-02       Impact factor: 3.143

7.  Convergent ERK1/2, p38 and JNK mitogen activated protein kinases (MAPKs) signalling mediate catecholoestradiol-induced proliferation of ovine uterine artery endothelial cells.

Authors:  Rosalina Villalon Landeros; Sheikh O Jobe; Gabrielle Aranda-Pino; Gladys E Lopez; Jing Zheng; Ronald R Magness
Journal:  J Physiol       Date:  2017-06-05       Impact factor: 5.182

8.  Phthalate metabolites and bisphenol-A in association with circulating angiogenic biomarkers across pregnancy.

Authors:  K K Ferguson; T F McElrath; D E Cantonwine; B Mukherjee; J D Meeker
Journal:  Placenta       Date:  2015-04-14       Impact factor: 3.481

9.  Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization.

Authors:  Vincent Fontaine; Cédric Filipe; Nikos Werner; Pierre Gourdy; Audrey Billon; Barbara Garmy-Susini; Laurent Brouchet; Francis Bayard; Hervé Prats; Thomas Doetschman; Georg Nickenig; Jean-François Arnal
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1.

Authors:  Frédéric Mouquet; François Cuilleret; Sophie Susen; Karine Sautière; Philippe Marboeuf; Pierre Vladimir Ennezat; Eugène McFadden; Pascal Pigny; Florence Richard; Bernadette Hennache; Marie Christine Vantyghem; Michel Bertrand; Jean Dallongeville; Brigitte Jude; Eric Van Belle
Journal:  Eur Heart J       Date:  2009-01-22       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.